Also called: Plasma-cell myeloma
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bones.
No one knows the exact causes of multiple myeloma, but it is more common in older people and African Americans. It can run in families. Common symptoms may include:
- Bone pain, often in the back or ribs
- Fractures (broken bones)
- Weakness or fatigue
- Weight loss
- Frequent infections and fevers
- Feeling very thirsty
- Frequent urination
Doctors diagnose multiple myeloma using lab tests, imaging tests, and a bone marrow biopsy. Your treatment depends on how advanced the disease is and whether you have symptoms. If you have no symptoms, you may not need treatment right away. If you have symptoms, you may have chemotherapy, stem cell transplantation, radiation, or targeted therapy. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.
It sits within Cancers and Immune System.
The lead U.S. institute for this subject is the National Cancer Institute.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Multiple Myeloma
3,997 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)National Cancer Institute (NCI)
- Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple MyelomaM.D. Anderson Cancer Center
- A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple MyelomaUmoja Biopharma
- Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic MalignanciesNational Cancer Institute (NCI)
- A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and LenalidomideJanssen Research & Development, LLC
- A Clinical Study of SHR-5421 in Patients With Multiple MyelomaSuzhou Suncadia Biopharmaceuticals Co., Ltd.
Research already completed
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- General Information about Plasma Cell Neoplasms (Including Multiple Myeloma)National Cancer Institute
- Multiple Myeloma: Patient HandbookInternational Myeloma Foundation
- MyelomaBlood Cancer United
Symptoms
- Multiple Myeloma Symptoms and CausesMayo Foundation for Medical Education and Research
Diagnosis and Tests
- Beta 2 Microglobulin (B2M) Tumor Marker TestNational Library of Medicine
- Blood Count Tests: MedlinePlus Health TopicNational Library of Medicine
- Bone Marrow TestsNational Library of Medicine
- Can Multiple Myeloma Be Found Early?American Cancer Society
- Free Light ChainsNational Library of Medicine
- Protein Electrophoresis by Immunofixation Blood TestNational Library of Medicine
Treatments and Therapies
- Bone Marrow Transplantation: MedlinePlus Health TopicNational Library of Medicine
- Drugs Approved for Multiple Myeloma and Other Plasma Cell NeoplasmsNational Cancer Institute
- Integrative Medicine and Complementary TherapiesBlood Cancer United
Living With
- Living as a Multiple Myeloma SurvivorAmerican Cancer Society
Related Issues
- AmyloidosisMayo Foundation for Medical Education and Research
- Monoclonal GammopathiesJohns Hopkins Medicine
- Questions to Ask about Multiple MyelomaAmerican Cancer Society
- Risk Factors for Multiple MyelomaAmerican Cancer Society
Genetics
- Multiple myeloma: MedlinePlus GeneticsNational Library of Medicine
Statistics and Research
- Advances in Multiple Myeloma ResearchNational Cancer Institute
- Key Statistics about Multiple MyelomaAmerican Cancer Society
- MyelomaNational Cancer Institute
Clinical Trials
- ClinicalTrials.gov: Multiple MyelomaNational Institutes of Health
- ClinicalTrials.gov: PlasmacytomaNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Multiple Myeloma. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Multiple Myeloma, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.